chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: right arm pain/ numbness; Numbness; Breast pain; Tingling in toes; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Breast pain), PAIN IN EXTREMITY (right arm pain/ numbness), HYPOAESTHESIA (Numbness) and PARAESTHESIA (Tingling in toes) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included AZITHROMYCIN (ZITHROMAX) for an unknown indication.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PARAESTHESIA (Tingling in toes). On 14-Feb-2021, the patient experienced BREAST PAIN (Breast pain). On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (right arm pain/ numbness) and HYPOAESTHESIA (Numbness). At the time of the report, BREAST PAIN (Breast pain), PAIN IN EXTREMITY (right arm pain/ numbness), HYPOAESTHESIA (Numbness) and PARAESTHESIA (Tingling in toes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Feb-2021: patient reported persistent pain in the arm and tingling in the toes since 07, FEB 2021.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue
Clinical narrative: diarrhea; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and FATIGUE (extreme fatigue) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and FATIGUE (extreme fatigue). At the time of the report, DIARRHOEA (diarrhea) and FATIGUE (extreme fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.     Reporter did not allow further contact
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Faeces discoloured
Clinical narrative: A bowel movement that it was red; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (A bowel movement that it was red) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced FAECES DISCOLOURED (A bowel movement that it was red). At the time of the report, FAECES DISCOLOURED (A bowel movement that it was red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Pyrexia, Rash
Clinical narrative: cherry red blot(patch) that is like a shape of boomerang 7 inches away from Injection site.; Temperature increased; Increased heart rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Increased heart rate), RASH (cherry red blot(patch) that is like a shape of boomerang 7 inches away from Injection site.) and PYREXIA (Temperature increased) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HEART RATE INCREASED (Increased heart rate) and PYREXIA (Temperature increased). On 19-Feb-2021, the patient experienced RASH (cherry red blot(patch) that is like a shape of boomerang 7 inches away from Injection site.). On 18-Feb-2021, HEART RATE INCREASED (Increased heart rate) and PYREXIA (Temperature increased) had resolved. At the time of the report, RASH (cherry red blot(patch) that is like a shape of boomerang 7 inches away from Injection site.) had not resolved.            Treatment information includes Acetaminophen (2 tablet).   Concomitant product use was not provided.   Action taken with the mRNA-1273 in response to event not applicable.    Reporter did not allow further contact
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain, Pruritus, Rash
Clinical narrative: sore throat; breakout of knuckle and elbo; itchy; itchy; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), RASH (breakout of knuckle and elbo; itchy), FATIGUE (tiredness) and PRURITUS (itchy) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 11-Jan-2021, the patient experienced FATIGUE (tiredness). On 21-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), RASH (breakout of knuckle and elbo; itchy) and PRURITUS (itchy). At the time of the report, OROPHARYNGEAL PAIN (sore throat), RASH (breakout of knuckle and elbo; itchy), FATIGUE (tiredness) and PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products are reported.  Treatment information include Benadryl, Aquaphor.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Hiccups, Nausea, Throat tightness
Clinical narrative: could not breathe; throat began to close; hiccupping; almost vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (could not breathe), THROAT TIGHTNESS (throat began to close), HICCUPS (hiccupping) and NAUSEA (almost vomiting) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced DYSPNOEA (could not breathe), THROAT TIGHTNESS (throat began to close), HICCUPS (hiccupping) and NAUSEA (almost vomiting). At the time of the report, DYSPNOEA (could not breathe), THROAT TIGHTNESS (throat began to close), HICCUPS (hiccupping) and NAUSEA (almost vomiting) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No Treatment for the event was provided.   No relevant Concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Warm to touch the injection site; Redness in the injection site; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch the injection site) and VACCINATION SITE ERYTHEMA (Redness in the injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for an unknown indication.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch the injection site) and VACCINATION SITE ERYTHEMA (Redness in the injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to touch the injection site) and VACCINATION SITE ERYTHEMA (Redness in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant  product use was not provided by the reporter. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body pain) and RASH (severe rash all over the legs) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.   On 22-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (severe rash all over the legs). On an unknown date, the patient experienced PAIN (Body pain). At the time of the report, PAIN (Body pain) outcome was unknown and RASH (severe rash all over the legs) had resolved.            Treatment information and relevant concomitant medications were also not provided.  Action taken with mRNA-1273 in response to the events was not reported.    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Influenza like illness, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Flu like symptoms; Joint aches; Muscle aches; Fever; Pain in the arm; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), ARTHRALGIA (Joint aches), MYALGIA (Muscle aches) and PYREXIA (Fever) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm). On 27-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), ARTHRALGIA (Joint aches), MYALGIA (Muscle aches) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Pain in the arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), ARTHRALGIA (Joint aches), MYALGIA (Muscle aches) and PYREXIA (Fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient denies allergies, past medical history and taking any concomitant medications. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pain, Pain in extremity, Pyrexia
Clinical narrative: arm sore; Feeling sick; pain all over body; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), MALAISE (Feeling sick), PAIN (pain all over body), PYREXIA (fever) and CHILLS (chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 01-Oct-2020.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore), MALAISE (Feeling sick), PAIN (pain all over body), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm sore) had not resolved and MALAISE (Feeling sick), PAIN (pain all over body), PYREXIA (fever) and CHILLS (chills) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site urticaria
Clinical narrative: Injection site urticaria; Injection site erythema; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE URTICARIA (Injection site urticaria) and VACCINATION SITE ERYTHEMA (Injection site erythema) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE URTICARIA (Injection site urticaria) and VACCINATION SITE ERYTHEMA (Injection site erythema). At the time of the report, VACCINATION SITE URTICARIA (Injection site urticaria) and VACCINATION SITE ERYTHEMA (Injection site erythema) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient's medication history  and treatment information were  not provided by the reporter
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Heart rate increased
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING and HEART RATE INCREASED in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FLUSHING (flushing face) and HEART RATE INCREASED (Fast hear rate). At the time of the report, FLUSHING (flushing face) and HEART RATE INCREASED (Fast hear rate) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Additional initial document received. Contact information updated
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot injection site; Itchy injection site; Site of injection started swelling; Pain at injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE PRURITUS (Itchy injection site), VACCINATION SITE SWELLING (Site of injection started swelling) and VACCINATION SITE PAIN (Pain at injection site) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE PRURITUS (Itchy injection site), VACCINATION SITE SWELLING (Site of injection started swelling) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE PRURITUS (Itchy injection site) and VACCINATION SITE SWELLING (Site of injection started swelling) outcome was unknown and VACCINATION SITE PAIN (Pain at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Advil was reported as treatment medication.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Vaccination site pain
Clinical narrative: Arm pain; head ache; myalgia; fatigue; arthralgia; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm pain), HEADACHE (head ache), MYALGIA (myalgia), FATIGUE (fatigue) and ARTHRALGIA (arthralgia) in a 42-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm pain), HEADACHE (head ache), MYALGIA (myalgia), FATIGUE (fatigue) and ARTHRALGIA (arthralgia). At the time of the report, VACCINATION SITE PAIN (Arm pain), HEADACHE (head ache), MYALGIA (myalgia), FATIGUE (fatigue) and ARTHRALGIA (arthralgia) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-019002 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bedridden, Chills, Headache, Lymphadenopathy
Clinical narrative: Could not get out of bed; Felt weak; Lymph nodes in the Groin area and Right Armpit hurts; Fever; Severe Chills; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Could not get out of bed), ASTHENIA (Felt weak), LYMPHADENOPATHY (Lymph nodes in the Groin area and Right Armpit hurts), PYREXIA (Fever) and CHILLS (Severe Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced ASTHENIA (Felt weak), LYMPHADENOPATHY (Lymph nodes in the Groin area and Right Armpit hurts), PYREXIA (Fever), CHILLS (Severe Chills), NAUSEA (Nausea) and HEADACHE (Headache). On an unknown date, the patient experienced BEDRIDDEN (Could not get out of bed). At the time of the report, BEDRIDDEN (Could not get out of bed), ASTHENIA (Felt weak), LYMPHADENOPATHY (Lymph nodes in the Groin area and Right Armpit hurts), PYREXIA (Fever), CHILLS (Severe Chills), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Could not get out of bed; Felt weak; Lymph nodes in the Groin area and Right Armpit hurts; Fever; Severe Chills; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Could not get out of bed), ASTHENIA (Felt weak), LYMPHADENOPATHY (Lymph nodes in the Groin area and Right Armpit hurts), PYREXIA (Fever) and CHILLS (Severe Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced ASTHENIA (Felt weak), LYMPHADENOPATHY (Lymph nodes in the Groin area and Right Armpit hurts), PYREXIA (Fever), CHILLS (Severe Chills), NAUSEA (Nausea) and HEADACHE (Headache). On an unknown date, the patient experienced BEDRIDDEN (Could not get out of bed). At the time of the report, BEDRIDDEN (Could not get out of bed), ASTHENIA (Felt weak), LYMPHADENOPATHY (Lymph nodes in the Groin area and Right Armpit hurts), PYREXIA (Fever), CHILLS (Severe Chills), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypoaesthesia, Myalgia
Clinical narrative: Muscle pain; Numbness; Lightheadedness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness), DIZZINESS (Lightheadedness), HEADACHE (Headache) and MYALGIA (Muscle pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness), DIZZINESS (Lightheadedness) and HEADACHE (Headache). On an unknown date, the patient experienced MYALGIA (Muscle pain). At the time of the report, HYPOAESTHESIA (Numbness), DIZZINESS (Lightheadedness), HEADACHE (Headache) and MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: The Non significant follow up case received on 27-APR-2021.Email information was added.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Feeling of body temperature change, Headache, Pyrexia
Clinical narrative: headache; Pain on her back; felt very hot and cold at the same time; her body was shaking because of how cold she felt; 100°F fever; lot of pain on the arm of the injection; A spontaneous report was received from a (Reporter like HCP,) concerning a 39  Years-old  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain in her back , felt very hot and cold at the same time, Her body was shaking because of how cold she felt,  100 F fever, a lot of pain on the arm of the injection,  100.2 F  fever, she did not feel good to go to work, headache.  The  patient's medical history include covid-19 positive in the month of may 2020   No relevant concomitant medications were reported.    On 26 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Jan 2021 after 3 hours after vaccination during her working hours in office the patient started to experience pain on the arm of injection,And that night after 10.30pm she felt very hot and cold at the same time and her body was shaking  because of how cold she felt, she had a 100°F fever. She also felt a lot of pain on her arm and on her back, on 27 Jan 2021  morning she had a 100.2°F fever,She did not feel  good to go to work, the symptoms went  away but she has a headache.   Treatment details if provided  include Tylenol for fever  Action taken with mRNA-1273 in response to the events was not reported.   On date, the outcome of the event(s) pain in her back , felt very hot and cold at the same time, Her body was shaking because of how cold she felt,  100 F fever, a lot of pain on the arm of the injection,  100.2 F  fever, she did not feel good to go to work, headache. were  considered Resolved on 27 Jan 2021   She made a comment that at work many people received the vaccine and only felt pain on their arms. Except for those that had had COVID-19, like herself, they had more side effects after receiving the vaccine.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: headache; Pain on her back; felt very hot and cold at the same time; her body was shaking because of how cold she felt; 100°F fever; lot of pain on the arm of the injection; A spontaneous report was received from a (Reporter like HCP,) concerning a 39  Years-old  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain in her back , felt very hot and cold at the same time, Her body was shaking because of how cold she felt,  100 F fever, a lot of pain on the arm of the injection,  100.2 F  fever, she did not feel good to go to work, headache.  The  patient's medical history include covid-19 positive in the month of may 2020   No relevant concomitant medications were reported.    On 26 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Jan 2021 after 3 hours after vaccination during her working hours in office the patient started to experience pain on the arm of injection,And that night after 10.30pm she felt very hot and cold at the same time and her body was shaking  because of how cold she felt, she had a 100°F fever. She also felt a lot of pain on her arm and on her back, on 27 Jan 2021  morning she had a 100.2°F fever,She did not feel  good to go to work, the symptoms went  away but she has a headache.   Treatment details if provided  include Tylenol for fever  Action taken with mRNA-1273 in response to the events was not reported.   On date, the outcome of the event(s) pain in her back , felt very hot and cold at the same time, Her body was shaking because of how cold she felt,  100 F fever, a lot of pain on the arm of the injection,  100.2 F  fever, she did not feel good to go to work, headache. were  considered Resolved on 27 Jan 2021   She made a comment that at work many people received the vaccine and only felt pain on their arms. Except for those that had had COVID-19, like herself, they had more side effects after receiving the vaccine.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Skin warm, Vaccination site pain
Clinical narrative: arm was a litter tender; experienced a large area of redness; skin was hot; Vaccination site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a litter tender), ERYTHEMA (experienced a large area of redness), SKIN WARM (skin was hot) and VACCINATION SITE PAIN (Vaccination site tenderness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was a litter tender), ERYTHEMA (experienced a large area of redness), SKIN WARM (skin was hot) and VACCINATION SITE PAIN (Vaccination site tenderness). At the time of the report, PAIN IN EXTREMITY (arm was a litter tender), ERYTHEMA (experienced a large area of redness), SKIN WARM (skin was hot) and VACCINATION SITE PAIN (Vaccination site tenderness) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.  No treatment medication was reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Injection site rash, Injection site swelling, Malaise
Clinical narrative: injection arm itchy; injection arm kind of hurt; injection arm  swollen; big red rash in the injection arm; she did not feel good; aches; pain; headaches; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (she did not feel good), PAIN (aches), PAIN (pain), HEADACHE (headaches) and VACCINATION SITE PRURITUS (injection arm itchy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced MALAISE (she did not feel good), PAIN (aches), PAIN (pain) and HEADACHE (headaches). On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection arm itchy), INJECTION SITE PAIN (injection arm kind of hurt), INJECTION SITE SWELLING (injection arm  swollen) and INJECTION SITE RASH (big red rash in the injection arm). At the time of the report, MALAISE (she did not feel good), PAIN (aches), PAIN (pain), HEADACHE (headaches), VACCINATION SITE PRURITUS (injection arm itchy), INJECTION SITE PAIN (injection arm kind of hurt), INJECTION SITE SWELLING (injection arm  swollen) and INJECTION SITE RASH (big red rash in the injection arm) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment medication was reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pruritus
Clinical narrative: injection arm itchy; injection arm kind of hurt; injection arm  swollen; big red rash in the injection arm; she did not feel good; aches; pain; headaches; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (she did not feel good), PAIN (aches), PAIN (pain), HEADACHE (headaches) and VACCINATION SITE PRURITUS (injection arm itchy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced MALAISE (she did not feel good), PAIN (aches), PAIN (pain) and HEADACHE (headaches). On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection arm itchy), INJECTION SITE PAIN (injection arm kind of hurt), INJECTION SITE SWELLING (injection arm  swollen) and INJECTION SITE RASH (big red rash in the injection arm). At the time of the report, MALAISE (she did not feel good), PAIN (aches), PAIN (pain), HEADACHE (headaches), VACCINATION SITE PRURITUS (injection arm itchy), INJECTION SITE PAIN (injection arm kind of hurt), INJECTION SITE SWELLING (injection arm  swollen) and INJECTION SITE RASH (big red rash in the injection arm) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Redness at injection site; Vaccination site pruritus; Rash at injection site; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE RASH (Rash at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE RASH (Rash at injection site). On 12-Jan-2021, VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE RASH (Rash at injection site) had resolved. Not Provided    For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment details included Cortisone, Benadryl (diphenydramine).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site warmth, Pruritus, Pyrexia
Clinical narrative: arm is still red and a little warm; itching; Fever; injection site warmth; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE WARMTH (injection site warmth), ERYTHEMA (arm is still red and a little warm), PRURITUS (itching) and PYREXIA (Fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 28L20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced INJECTION SITE WARMTH (injection site warmth), PRURITUS (itching) and PYREXIA (Fever). On 03-Feb-2021, the patient experienced ERYTHEMA (arm is still red and a little warm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at an unspecified dose and frequency. On 03-Feb-2021, INJECTION SITE WARMTH (injection site warmth) outcome was unknown, PRURITUS (itching) and PYREXIA (Fever) had resolved. At the time of the report, ERYTHEMA (arm is still red and a little warm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Muscular weakness, Pain in extremity
Clinical narrative: muscle weakness; arm soreness; headaches; fatigue; This spontaneous case was reported by a health care professional and describes the occurrence of   in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Iodine allergy, Latex allergy (allergic to morphine and flagyl also), Drug allergy, Allergy to antibiotic, Autoimmune disorder NOS (attacks her joints especially the right foot, ankle and calf.) and Breast implant user. Concomitant products included ESTRADIOL (ESTRING) for Estradiol abnormal, TESTOSTERONE for Hormone therapy, ESTRADIOL (ESTRADIOL TRANSDERMAL) for Hysterectomy, LEVOTHYROXINE SODIUM (UNITHROID) and LIOTHYRONINE SODIUM (CYTOMEL) for Thyroid disorder NOS.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient did not use any treatment medication.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: systemic rash on torso and arms; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of RASH (systemic rash on torso and arms) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included INTRAUTERINE CONTRACEPTIVE DEVICE (IUD NOS) for Contraception.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (systemic rash on torso and arms). At the time of the report, RASH (systemic rash on torso and arms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included IUD but was not taking any medications. Treatment medication was not reported.  The systemic rash developed the last 24hrs (torso and arms) and was not itchy.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Got diarrhoea 2 days following second Moderna vaccine injection; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Got diarrhoea 2 days following second Moderna vaccine injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced DIARRHOEA (Got diarrhoea 2 days following second Moderna vaccine injection). On 20-Feb-2021, DIARRHOEA (Got diarrhoea 2 days following second Moderna vaccine injection) had resolved.            Concomitant medication was not reported. Treatment medication was not reported.    Reporter did not allow further contact
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: mild Headache; severe fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (mild Headache) and FATIGUE (severe fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ADDEROLL (ADEROLL) for an unknown indication.    On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced HEADACHE (mild Headache) and FATIGUE (severe fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, HEADACHE (mild Headache) outcome was unknown and FATIGUE (severe fatigue) had not resolved.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Dysuria, Fatigue, Headache, Myalgia
Clinical narrative: difficulty passing urine; Back pain; Fatigue; Body ache; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (difficulty passing urine), BACK PAIN (Back pain), FATIGUE (Fatigue), MYALGIA (Body ache) and PYREXIA (Fever) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Body ache), PYREXIA (Fever) and HEADACHE (Headache). On 21-Feb-2021, the patient experienced DYSURIA (difficulty passing urine) and BACK PAIN (Back pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DYSURIA (difficulty passing urine), BACK PAIN (Back pain), FATIGUE (Fatigue), MYALGIA (Body ache), PYREXIA (Fever) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: difficulty passing urine; Back pain; Fatigue; Body ache; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (difficulty passing urine), BACK PAIN (Back pain), FATIGUE (Fatigue), MYALGIA (Body ache) and PYREXIA (Fever) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Body ache), PYREXIA (Fever) and HEADACHE (Headache). On 21-Feb-2021, the patient experienced DYSURIA (difficulty passing urine) and BACK PAIN (Back pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DYSURIA (difficulty passing urine), BACK PAIN (Back pain), FATIGUE (Fatigue), MYALGIA (Body ache), PYREXIA (Fever) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Lot of pain; A spontaneous report was received from a consumer concerning a 85-years-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced lot of pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 13 Jan 2021, the patient experienced the event of lot of pain.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event lot of pain was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Feeling hot, Pain in extremity, Peripheral swelling, Vaccination site erythema
Clinical narrative: Arm is hot to the touch; Red mark of 2 by 3 inches at the site of the injection; Armpit was swollen; Arm was very sore; Arm was swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Arm was very sore), PERIPHERAL SWELLING (Arm was swollen), AXILLARY MASS (Armpit was swollen), FEELING HOT (Arm is hot to the touch) and VACCINATION SITE ERYTHEMA (Red mark of 2 by 3 inches at the site of the injection) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's medical history was not provided.  Concomitant products included GABAPENTIN for Restless leg syndrome.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was very sore) and PERIPHERAL SWELLING (Arm was swollen). On 01-Feb-2021, the patient experienced AXILLARY MASS (Armpit was swollen). On 02-Feb-2021, the patient experienced FEELING HOT (Arm is hot to the touch) and VACCINATION SITE ERYTHEMA (Red mark of 2 by 3 inches at the site of the injection). The patient was treated with Manual therapy (Ice, drank lots of fluid and warm compress) for Peripheral swelling. On 26-Jan-2021, PAIN IN EXTREMITY (Arm was very sore) and PERIPHERAL SWELLING (Arm was swollen) had resolved. At the time of the report, AXILLARY MASS (Armpit was swollen), FEELING HOT (Arm is hot to the touch) and VACCINATION SITE ERYTHEMA (Red mark of 2 by 3 inches at the site of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient's arm got very sore and swollen. She put some ice on it and drunk a lot of fluids and the symptoms went away after 24 hours. Last night (01-FEB-2021) she noticed her armpit was swollen, so she put a warm compress on it. Today (02-FEB-2021), the arm is swollen again, and it is hot to the touch and has a red mark of 2 by 3 inches at the site of the injection.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: Lumpiness at the site of injection; Itching at the site of injection; Redness at the site of injection; lumpiness at the site of injection; redness at the injection site; itchiness at the site of injection; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE MASS (lumpiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE PRURITUS (Itching at the site of injection) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (itchiness at the site of injection) and VACCINATION SITE MASS (lumpiness at the site of injection). On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE PRURITUS (Itching at the site of injection) and VACCINATION SITE MASS (Lumpiness at the site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of UNK dosage form. In January 2021, VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE MASS (lumpiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE PRURITUS (Itching at the site of injection) and VACCINATION SITE MASS (Lumpiness at the site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient developed redness, itchiness and lumpiness at the site of the injection that lasted for 4-5 days and then faded. Then, on the 8th day, the reaction came back and lasted for around 3 days.